Correlation Between Neurocrine Biosciences and LILLY
Specify exactly 2 symbols:
By analyzing existing cross correlation between Neurocrine Biosciences and LILLY ELI 275, you can compare the effects of market volatilities on Neurocrine Biosciences and LILLY and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of LILLY. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and LILLY.
Diversification Opportunities for Neurocrine Biosciences and LILLY
-0.43 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Neurocrine and LILLY is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and LILLY ELI 275 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LILLY ELI 275 and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with LILLY. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LILLY ELI 275 has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and LILLY go up and down completely randomly.
Pair Corralation between Neurocrine Biosciences and LILLY
Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 5.85 times more return on investment than LILLY. However, Neurocrine Biosciences is 5.85 times more volatile than LILLY ELI 275. It trades about 0.02 of its potential returns per unit of risk. LILLY ELI 275 is currently generating about 0.0 per unit of risk. If you would invest 12,008 in Neurocrine Biosciences on September 24, 2024 and sell it today you would earn a total of 1,534 from holding Neurocrine Biosciences or generate 12.77% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 86.12% |
Values | Daily Returns |
Neurocrine Biosciences vs. LILLY ELI 275
Performance |
Timeline |
Neurocrine Biosciences |
LILLY ELI 275 |
Neurocrine Biosciences and LILLY Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Neurocrine Biosciences and LILLY
The main advantage of trading using opposite Neurocrine Biosciences and LILLY positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, LILLY can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LILLY will offset losses from the drop in LILLY's long position.Neurocrine Biosciences vs. Fate Therapeutics | Neurocrine Biosciences vs. Sana Biotechnology | Neurocrine Biosciences vs. Caribou Biosciences | Neurocrine Biosciences vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |